Showing results (81-90 of 216) with videos related to
Sort By:
Pageof 22
Frontiers in Immunology|July 5, 2022
Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-FutureJosé Saura-Esteller, Milon de Jong, Lisa A King, et al.Journal for Immunotherapy of Cancer|December 1, 2023
Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactionsRoeland Lameris, Adam Shahine, Myrthe Veth, et al.Vaccine|March 10, 2018
A safety and immunogenicity study of immunization with hVEGF26-104/RFASE in cynomolgus monkeysMadelon Q Wentink, Henk M W Verheul, Arjan W Griffioen, et al.Plos One|June 18, 2016
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal CancerJohn Pradeep Veluchamy, Jan Spanholtz, Marleen Tordoir, et al.Clinical Orthopaedics and Related Research|April 16, 2019
Polytrauma and High-energy Injury Mechanisms are Associated with Worse Patient-reported Outcomes After Distal Radius FracturesQ M J van der Vliet, A A R Sweet, A R Bhashyam, et al.Genes & Development|April 15, 2026
KLF18 is a necessary component of the DUX4-initiated transcriptional network and a candidate locus for phenotypic diversityDanielle C Hamm, Aidan B O'Donnell, Sean R Bennett, et al.Journal of Immunological Methods|March 9, 2007
Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacityJohan W Molling, Maria Moreno, Hans J J van der Vliet, et al.Cancers|November 26, 2022
Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-AnalysisInge M Werter, Sharon Remmelzwaal, George L Burchell, et al.International Journal of Molecular Sciences|January 27, 2021
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple MyelomaRenée Poels, Esther Drent, Roeland Lameris, et al.Clinical Immunology (Orlando, Fla.)|September 12, 2008
Invariant natural killer T cells and immunotherapy of cancerJohan W Molling, María Moreno, Hans J J van der Vliet, et al.Pageof 22